P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: Pivotal Results from BOND-003: A Phase 3, Single-arm Study of Intravesical Cretostimogene Grenadenorepvec for the Treatment of High Risk, BCG-Unresponsive Non-Muscle Invasive Bladder C
Friday, May 3, 2024 10:23 AM to 10:31 AM · 8 min. (US/Central)
Stars at Night Ballroom
Detail